The Innovation and Value Initiative (IVI) appoints Patricia Deverka, MD, as its first Chief Science Officer.
ALEXANDRIA, Va., February 4, 2020 — The Innovation and Value Initiative (IVI), whose mission is to strengthen value assessment in healthcare that reflects its five principles of scientific rigor, transparency, patient centricity, innovation and market-based solutions, today announced that Patricia Deverka, MD, has joined the non-profit as its first Chief Science Officer. With close to 30 years of experience in the fields of health economics and outcomes research, health policy, stakeholder engagement and business development for corporations and non-profits alike, Dr. Deverka joins IVI from Geisinger National Precision Health, where she was the director for value evidence and outcomes. She is also a member of the National Human Genome Research Institute and National Advisory Council and has published on topics ranging from innovative technologies to patient engagement.
“We are excited to welcome Dr. Deverka to our team,” said Jennifer Bright, IVI’s executive director. “Her varied experience in health economics research, especially her work to meaningfully incorporate patient perspectives into clinical studies, are exactly the credentials that are needed to make a difference in the world of value assessment.”
For more on Dr. Deverka’s appointment, you can read the full press release.
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More